Arca
Skip to content

Sensorineural hearing loss

Drug research and approvals for sensorineural hearing loss: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 91 studies of sensorineural hearing loss are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and FDA has 1 approved and 3 open orphan designations naming it.

  • Recruiting worldwide: 91
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 1
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 91 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Sep 25, 2026A trial of aavanc80-hotof gene therapy in individuals with sensorineural hearing loss due to otoferlin gene (otof) mutationsAAVANC80-HOTOFEli LillyPending
May 1, 2026Usability of the intracochlear catheter incat a pilot feasability studyDEXAMETHASONE / N-ACETYLCYSTEINE / TRIAMCINOLONESUNNYBROOK RESEARCH INSTITUTEPending
Nov 29, 2024Usability of the intracochlear catheter incat - a pilot feasibility studyDEXAMETHASONE / TRIAMCINOLONE / ACETYLCYSTEINESUNNYBROOK RESEARCH INSTITUTEPending
Nov 15, 2024A phase I/ii clinical trial with sens-501 in children suffering from severe to profound hearing loss due to otoferlin (otof) mutationsSENS-501SENSORIONPending
Sep 28, 2018A two-part, randomised, double-blind, placebo-controlled, parallel-group, efficacy and safety study of sens-401 in subjects with severe or profound sudden…AZASETRON (SENS-401)SENSORIONClosed

FDA Orphan Designations

Approved first, then open designations, newest first
Apr 23, 2026Otarmenitreatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any frequency >90 dB HL)…Regeneron Pharmaceuticals, Inc.Approved
May 10, 20216-fluoro-9-methyl-9H-pyrido[3,4-b]-indoleTreatment of Sudden Sensorineural Hearing LossAudioCure Pharma GmbHDesignated
Dec 12, 2019pioglitazoneTreatment of sudden sensorineural hearing lossStrekin AGDesignated
Mar 28, 2006(UDU-stereoisomer of c-UJUun UNU-terminal UkUnhibitor)Treatment of acute sensorineural hearing lossAltamira Therapeutics Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.